ELEDON PHARMACEUTICALS
5.0700
06-November-24 14:59:47
15 minutes delayed
Stocks
+0.0800
+1.60%
Today's range
5.0100 - 5.3999
ISIN
N/A
Source
NASDAQ
-
06 Nov 2024 15:05:00 By Nasdaq GlobeNewswire
-
29 Oct 2024 06:46:00 By Nasdaq GlobeNewswire
-
Eledon Pharmaceuticals to Present at the Cantor Global Healthcare Conference
11 Sep 2024 15:05:00 By Nasdaq GlobeNewswire
-
04 Sep 2024 06:00:00 By Nasdaq GlobeNewswire
-
Eledon Pharmaceuticals Reports Preliminary Second Quarter 2024 Operating Results
14 Aug 2024 16:21:26 By Nasdaq GlobeNewswire
-
29 Jul 2024 06:00:00 By Nasdaq GlobeNewswire
-
Eledon to Participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism
02 Jul 2024 15:05:00 By Nasdaq GlobeNewswire
-
03 Jun 2024 15:01:00 By Nasdaq GlobeNewswire
-
Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results
09 May 2024 06:30:00 By Nasdaq GlobeNewswire
-
09 May 2024 06:00:01 By Nasdaq GlobeNewswire
-
Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection
07 May 2024 06:05:00 By Nasdaq GlobeNewswire
-
Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement
07 May 2024 06:00:01 By Nasdaq GlobeNewswire
-
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results
28 Mar 2024 15:01:00 By Nasdaq GlobeNewswire
-
25 Mar 2024 15:56:42 By Nasdaq GlobeNewswire
-
21 Mar 2024 09:31:12 By Nasdaq GlobeNewswire
-
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13 Feb 2024 18:01:00 By Nasdaq GlobeNewswire
-
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook
04 Jan 2024 15:40:44 By Nasdaq GlobeNewswire
-
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 Dec 2023 17:00:00 By Nasdaq GlobeNewswire
-
Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference
29 Nov 2023 15:05:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >